Please login to the form below

Not currently logged in
Email:
Password:

Tredaptive

This page shows the latest Tredaptive news and features for those working in and with pharma, biotech and healthcare.

FDA rejects Merck muscle relaxant drug once again

FDA rejects Merck muscle relaxant drug once again

this year after disappointments such as the failure of cholesterol drug Tredaptive (extended-release niacin/laropiprant).

Latest news

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Closing the treatment gap

    This included a global release available at the press event and distribution over the wires, a glossy media guide to cardiovascular disease, fact sheets on heart disease, Merck’s drug Tredaptive

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics